GENERAL COMMENTS
This is a single arm intervention study assessing the impact of CGA on drug prescribing in primary care. Given the design of the study and the lack of a control group it is not possible to say if the observed change in drug prescribing is due to the CGA intervention or this might be an effect due to participation to the study. Therefore, the only conclusion that can be drawn from the study is that CGA is feasible in primary care.
Also, only 7 of the 15 invited GP practices did participate to the study. This might represent a very selected sample of very motivated GP and threfore results might not be generalizable to all GP practices.
Also the type intervention provided is not appropriately defined. CGA is usually associated with multidisciplianry management based on a multidisciplinary team approach. In this case the intervention is based on a geriatric consultation service rather than on a CGA and management approach.
No information is provided on the methodology of CGA. Did the CGA follow a standardized procedure? Is it performed by the use of standardized assessment instruments? If the intervention is not standardized it can not be replicated in other contexts/practices.
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GENERAL COMMENTS
In places I would like more data and expansion on CGA outcomes. I know this may be difficult due to word limit.
1) Two references that you should include to up-date work are the NICE multi-morbidity guidelines (pg 3, line 55 needs to be updated), and the Cochrane review on Hospital at home by Shepheard et al. 2) Clarify how frailty was defined and measured in this work 3) Pg 5 Line 23-How many people initially identified by GPS (contextualise the extent of need for CGA in primary care) . Also report how many people refused/declined to participate 4) Pg 6 follow-up clarify how data was accessed 5) Results section: I come back to my original point is it possible to articulate the other non-pharmacology recommendations resulting from CGA, you briefly alluded to identification of people at End of Life, is it possible to provide more details on what changes/ recommendations were made? 6) Provide more detail on the main types of drug modifications ratherthan just the numbers 7) Pg 8, place of residence outcomes at 6 and 12 months could be reported in Table 3 , this is an important outcome in CGA and it is difficult to compare when just described in text 8) Table 3 use of the word adherence, although explained is confusing ass it has a particular meaning in relation to drugs that is patient adherence to therapy is it compliance /accepted /sustained change 9) Health care utilisation pg 8 line 48 service utilisation was described as stable-more useful to report the actual number 10) Pg 8 last paragraph The increase in emergency utilisation is it possible to examine if there was a small group of the most frail or was it across the whole group. 11) The discussion focuses narrowly on medication optimisation; while this is the main outcome measure of the impact of CGA in this article , you need to articulate why you need a geriatrician using CGA rather than a pharmacist doing medication reconciliation, which is a component of CGA. 12) I think the increase in health care utilisation is interesting and while without a RCT you cannot attribute it to CGA, it raises the interesting prospects that the benefits of CGA seen in acute care may not be replicated in primary care. This could be discussed more fully in the discussion and build the argument for a RCT
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GENERAL COMMENTS
While the objective of determining the feasibility of CGA in a general practice care setting was met in this paper -the evaluation of potential clinical benefits was not. What was accomplished in the study was an evaluation of adherence to CGA recommendations and a reduction in polypharmacy rather than an actual evaluation of clinical benefit. While the discussion about interactions with healthcare utilization is of interest it does not include much of a cost analysis making it difficult to determine whether the CGA decreases costs or not. 
REVIEWER
GENERAL COMMENTS
I. Line 24 -Should reference be made in the abstract to the total number of patients assessed? ie 186 II. Line 54-56 -Consider revising this sentence. I aslo feel "CCG" should not be abbreviated. III. Line 19-21 -I agree that further investigation is warranted on why less than have of GPs opted to take part in the study. IV. Overall I agree that this study adds further to the literature re the role of secondary gertriatrians in primary care. Further studies -in the form of a RCT as suggested -may certainly be of value in evaluating this.
VERSION 1 -AUTHOR RESPONSE
We have made modifications to the manuscript which we would like you to consider for publication. Thank you.
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GENERAL COMMENTS
Authors have addressed the comments I raised
